Iterum Therapeutics Plc

NASDAQ:ITRM  
0.55
+0.01 (+1.18%)
Earnings Announcements

Iterum Therapeutics Posts Qtrly Loss Per Share $0.28

Published: 03/12/2021 12:49 GMT
Iterum Therapeutics Plc (ITRM) - Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results.
Iterum Therapeutics Plc - NDA for Oral Sulopenem Has PDUFA Date of July 25, 2021.
Iterum Therapeutics Plc - Cash Runway Into First Half of 2023.
Iterum Therapeutics Plc - As of December 31, 2020, Iterum Had Cash and Cash Equivalents of $14.5 Million.
Iterum Therapeutics Plc Qtrly Loss per Share $0.28.
Iterum Therapeutics Plc Qtrly Adjusted.
Loss per Share $0.11.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.